SOURCE [1]Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients www.marketwatch.com Dec. 7, 2008 |
VELCADE (Bortezomib) January 3, 2009 |
NEWS December 2008 Data presented at the 50th Annual Meeting of the American Society of Hematology (ASH), held December 5-9, 2008 in San Francisco, suggested the combination of four drugs (VELCADE, dexamethasone, cyclophosphamide and lenalidomide (VcDCR)) was with previously untreated multiple myeloma (MM). [1] |